These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9189226)

  • 1. A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
    Coulaud IP; Gougeon ML; Gomard E; Descamps D; Lebon P; Aboulker JP; Bizzini B; Zagury D
    AIDS; 1997 Jun; 11(7):937-8. PubMed ID: 9189226
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS vaccine trial disappointing.
    Science; 1996 Apr; 272(5260):341. PubMed ID: 8602519
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
    DeMaria A; Kunches L; Mayer K; Cohen C; Epstein P; Werner B; Day J; DeCristofaro J; Landers S; Tang Y; Coady W
    J Hum Virol; 2000; 3(4):182-92. PubMed ID: 10990166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for control of HIV infections.
    Sharma KB
    J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic vaccines for chronic infections.
    Autran B; Carcelain G; Combadiere B; Debre P
    Science; 2004 Jul; 305(5681):205-8. PubMed ID: 15247470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines repress HIV in children.
    AIDS Patient Care STDS; 1996 Dec; 10(6):381. PubMed ID: 11361573
    [No Abstract]   [Full Text] [Related]  

  • 8. Policy rebuttal. HIV vaccine trial justified.
    McNeil JG; Johnston MI; Birx DL; Tramont EC
    Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
    [No Abstract]   [Full Text] [Related]  

  • 9. Thailand's Prime-Boost HIV Vaccine Phase III.
    Trinvuthipong C
    Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.
    Longo O; Tripiciano A; Fiorelli V; Bellino S; Scoglio A; Collacchi B; Alvarez MJ; Francavilla V; Arancio A; Paniccia G; Lazzarin A; Tambussi G; Din CT; Visintini R; Narciso P; Antinori A; D'Offizi G; Giulianelli M; Carta M; Di Carlo A; Palamara G; Giuliani M; Laguardia ME; Monini P; Magnani M; Ensoli F; Ensoli B
    Vaccine; 2009 May; 27(25-26):3306-12. PubMed ID: 19208456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remune trial will stop; new trials planned.
    James JS
    AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in development and testing of novel recombinant vaccine platforms for HIV.
    Weiner DB
    Springer Semin Immunopathol; 2006 Nov; 28(3):195-6. PubMed ID: 17043866
    [No Abstract]   [Full Text] [Related]  

  • 14. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
    Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.
    Ratto-Kim S; Sitz KV; Garner RP; Kim JH; Davis C; Aronson N; Ruiz N; Tencer K; Redfield RR; Birx DL
    J Infect Dis; 1999 Feb; 179(2):337-44. PubMed ID: 9878016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A primer on HIV type 1-specific immune function and REMUNE.
    Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial suggests vaccines could aid HIV therapy.
    Check E
    Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune enhancement trial begins.
    AIDS Patient Care STDS; 1996 Aug; 10(4):263. PubMed ID: 11361606
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
    Birx DL; Loomis-Price LD; Aronson N; Brundage J; Davis C; Deyton L; Garner R; Gordin F; Henry D; Holloway W; Kerkering T; Luskin-Hawk R; McNeil J; Michael N; Foster Pierce P; Poretz D; Ratto-Kim S; Renzullo P; Ruiz N; Sitz K; Smith G; Tacket C; Thompson M; Tramont E; Yangco B; Yarrish R; Redfield RR
    J Infect Dis; 2000 Mar; 181(3):881-9. PubMed ID: 10720508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.
    Fernandez-Cruz E; Moreno S; Navarro J; Clotet B; Bouza E; Carbone J; Peña JM; Pérez Molina J; Podzamczer D; Rubio R; Ocaña I; Pulido F; Viciana P; Maradona JA; Blazquez R; Barros C; Quereda C; Rodriguez-Sainz C; Gil J; Abad ML; Díaz L; Cantó C; Muñoz MA; Ferrer E; Jou A; Sirera G; Díaz M; Lopez F; Gatell JM; Gonzalez-Lahoz J;
    Vaccine; 2004 Aug; 22(23-24):2966-73. PubMed ID: 15297045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.